Slide Insurance Holdings, Inc.·4

May 6, 4:02 PM ET

LARSON MATTHEW PAUL 4

4 · Slide Insurance Holdings, Inc. · Filed May 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Slide Insurance (SLDE) CRO Matthew Larson Exercises Options, Sells Shares

What Happened

  • Matthew Paul Larson, Chief Risk Officer of Slide Insurance (SLDE), exercised stock options and then sold the resulting shares on May 4, 2026.
  • He exercised 5,000 options at $0.79 per share (cost $3,950) and sold 5,000 common shares in an open‑market sale for a weighted average price of $18.57, yielding approximately $92,850.
  • The filing also shows a derivative conversion line (5,000 shares @ $0.00) reflecting the conversion/transfer step in the exercise/sale process.

Key Details

  • Transaction date: May 4, 2026; Form 4 filed May 6, 2026 (timely within the two‑business‑day reporting window).
  • Exercise: 5,000 options at $0.79 each (total $3,950).
  • Sale: 5,000 shares sold, weighted avg price $18.57; proceeds ≈ $92,850. Sale prices ranged from $18.30 to $19.01 per share (filing footnote).
  • Shares owned after transaction: not specified in the provided excerpt of the filing.
  • Footnotes: Transactions were executed pursuant to a 10b5‑1 trading plan adopted Dec 4, 2025 (pre‑arranged). The options exercised are fully vested and exercisable.

Context

  • The sequence (exercise followed by immediate sale) is a common cashless or pre‑planned option exercise/sale used to realize gains; the 10b5‑1 plan indicates the trades were pre‑scheduled and not ad hoc. This is typically viewed as routine insider liquidity rather than a direct signal about company prospects.

Insider Transaction Report

Form 4
Period: 2026-05-04
LARSON MATTHEW PAUL
Chief Risk Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-04$0.79/sh+5,000$3,9505,000 total
  • Sale

    Common Stock

    [F1][F2]
    2026-05-04$18.57/sh5,000$92,8500 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F3]
    2026-05-045,00050,248 total
    Exercise: $0.79Exp: 2032-02-24Common Stock (5,000 underlying)
Footnotes (3)
  • [F1]Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025.
  • [F2]Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.30 to $19.01 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
  • [F3]These stock options are fully vested and exercisable.
Signature
/s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson|2026-05-06

Documents

1 file
  • 4
    ownership.xmlPrimary

    4